Cancer immunotherapy: Past Progress and Future Directions

被引：17

作者：

Atkins, Michael B. ^{[1
]}

Sznol, Mario ^{[2
,3
]}

机构：

[1] Georgetown Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA

[2] Yale Canc Ctr, Dept Internal Med, New Haven, CT USA

[3] Yale Canc Ctr, Melanoma Unit, New Haven, CT USA

来源：

SEMINARS IN ONCOLOGY | 2015年 / 42卷 / 04期

关键词：

METASTATIC MELANOMA; RECOMBINANT INTERLEUKIN-2; THERAPY; CELLS; IPILIMUMAB; ANTIBODY; DISEASE; SAFETY;

D O I：

10.1053/j.seminoncol.2015.05.001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：518 / 522

页数：5

共 18 条

[1]

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993 [J].

Atkins, MB ;

Lotze, MT ;

Dutcher, JP ;

Fisher, RI ;

Weiss, G ;

Margolin, K ;

Abrams, J ;

Sznol, M ;

Parkinson, D ;

Hawkins, M ;

Paradise, C ;

Kunkel, L ;

Rosenberg, SA .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :2105-2116

[2]

Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens [J].

Dudley, Mark E. ;

Yang, James C. ;

Sherry, Richard ;

Hughes, Marybeth S. ;

Royal, Richard ;

Kammula, Udai ;

Robbins, Paul F. ;

Huang, JianPing ;

Citrin, Deborah E. ;

Leitman, Susan F. ;

Wunderlich, John ;

Restifo, Nicholas P. ;

Thomasian, Armen ;

Downey, Stephanie G. ;

Smith, Franz O. ;

Klapper, Jacob ;

Morton, Kathleen ;

Laurencot, Carolyn ;

White, Donald E. ;

Rosenberg, Steven A. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (32) :5233-5239

[3]

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients [J].

Herbst, Roy S. ;

Soria, Jean-Charles ;

Kowanetz, Marcin ;

Fine, Gregg D. ;

Hamid, Omid ;

Gordon, Michael S. ;

Sosman, Jeffery A. ;

McDermott, David F. ;

Powderly, John D. ;

Gettinger, Scott N. ;

Kohrt, Holbrook E. K. ;

Horn, Leora ;

Lawrence, Donald P. ;

Rost, Sandra ;

Leabman, Maya ;

Xiao, Yuanyuan ;

Mokatrin, Ahmad ;

Koeppen, Hartmut ;

Hegde, Priti S. ;

Mellman, Ira ;

Chen, Daniel S. ;

Hodi, F. Stephen .

NATURE, 2014, 515 (7528) :563-+

[4]

Long-term survival of ipilimumab-naive patients (pts) with advanced melanoma (MEL) treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) in a phase I trial. [J].

Hodi, F. Stephen ;

Sznol, Mario ;

Kluger, Harriet M. ;

McDermott, David F. ;

Carvajal, Richard D. ;

Lawrence, Donald P. ;

Topalian, Suzanne Louise ;

Atkins, Michael B. ;

Powderly, John D. ;

Sharfman, William Howard ;

Puzanov, Igor ;

Smith, David C. ;

Leming, Philip D. ;

Lipson, Evan J. ;

Taube, Janis M. ;

Anders, Robert ;

Horak, Christine E. ;

Kollia, Georgia ;

Gupta, Ashok Kumar ;

Sosman, Jeffrey Alan .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

[5]

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma [J].

Hodi, F. Stephen ;

O'Day, Steven J. ;

McDermott, David F. ;

Weber, Robert W. ;

Sosman, Jeffrey A. ;

Haanen, John B. ;

Gonzalez, Rene ;

Robert, Caroline ;

Schadendorf, Dirk ;

Hassel, Jessica C. ;

Akerley, Wallace ;

van den Eertwegh, Alfons J. M. ;

Lutzky, Jose ;

Lorigan, Paul ;

Vaubel, Julia M. ;

Linette, Gerald P. ;

Hogg, David ;

Ottensmeier, Christian H. ;

Lebbe, Celeste ;

Peschel, Christian ;

Quirt, Ian ;

Clark, Joseph I. ;

Wolchok, Jedd D. ;

Weber, Jeffrey S. ;

Tian, Jason ;

Yellin, Michael J. ;

Nichol, Geoffrey M. ;

Hoos, Axel ;

Urba, Walter J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) :711-723

[6]

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group trial EST 1684 [J].

Kirkwood, JM ;

Strawderman, MH ;

Ernstoff, MS ;

Smith, TJ ;

Borden, EC ;

Blum, RH .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) :7-17

[7]

COMPARISON OF INTRAMUSCULAR AND INTRAVENOUS RECOMBINANT ALPHA-2 INTERFERON IN MELANOMA AND OTHER CANCERS [J].

KIRKWOOD, JM ;

ERNSTOFF, MS ;

DAVIS, CA ;

REISS, M ;

FERRARESI, R ;

RUDNICK, SA .

ANNALS OF INTERNAL MEDICINE, 1985, 103 (01) :32-36

[8]

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia [J].

Maude, Shannon L. ;

Frey, Noelle ;

Shaw, Pamela A. ;

Aplenc, Richard ;

Barrett, David M. ;

Bunin, Nancy J. ;

Chew, Anne ;

Gonzalez, Vanessa E. ;

Zheng, Zhaohui ;

Lacey, Simon F. ;

Mahnke, Yolanda D. ;

Melenhorst, Jan J. ;

Rheingold, Susan R. ;

Shen, Angela ;

Teachey, David T. ;

Levine, Bruce L. ;

June, Carl H. ;

Porter, David L. ;

Grupp, Stephan A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (16) :1507-1517

[9]

BCG IMMUNOTHERAPY OF MALIGNANT-MELANOMA - SUMMARY OF A 7-YEAR EXPERIENCE [J].

MORTON, DL ;

EILBER, FR ;

HOLMES, EC ;

HUNT, JS ;

KETCHAM, AS ;

SILVERSTEIN, MJ ;

SPARKS, FC .

ANNALS OF SURGERY, 1974, 180 (04) :635-643

[10]

Efficacy and Safety of Retreatment with Ipilimumab in Patients with Pretreated Advanced Melanoma Who Progressed after Initially Achieving Disease Control [J].

Robert, Caroline ;

Schadendorf, Dirk ;

Messina, Marianne ;

Hodi, F. Stephen ;

O'Day, Steven .

CLINICAL CANCER RESEARCH, 2013, 19 (08) :2232-2239

← 1 2 →